-
2023-508208-40-00
10
2024-11-21
All adult patients with successful transfemoral trans-aortic valve imp
-
2024-515219-23-00
3
2024-11-08
multiple myeloma
-
2024-514886-21-00
6
2024-11-06
Pemphigus diseases (Pemphigus Vulgaris - PV and Pemphigus Foliaceus
(P
-
2024-514099-41-00
5
2024-10-31
Alzheimer's disease
-
2023-504755-26-00
4
2024-10-21
Bronchiectasis
-
2024-515300-39-00
4
2024-10-18
METASTATIC GRADE 3 POORLY DIFFERENTIATED NEUROENDOCRINE CARCINOMA OF G
-
2023-507353-15-00
5
2024-09-10
idiopathic pulmonary fibrosis (IPF)
-
2024-513087-26-00
5
2024-09-10
Metastatic Non-small Cell Lung Cancer
-
2024-512872-36-00
5
2024-07-25
obstetric_pathological delivery
-
2023-509905-62-00
5
2024-07-19
Lower limb trauma requiring immobilisation
-
2023-508162-15-00
5
2024-07-12
Chronic HF and comorbid impairment of kidney function who had a recent
-
2023-509648-88-00
9
2024-07-09
Peripheral T cells lymphoma (PTCL)
-
2024-512004-19-01
5
2024-07-02
Head trauma
-
2023-505214-23-00
5
2024-06-07
colon carcinoma
-
2023-506721-11-00
5
2024-06-04
Familial Mediterranean Fever (FMF)
-
2022-502092-33-00
4
2024-05-31
Extensive-disease small cell lung cancer and high SLFN11-expression
-
2024-516456-17-00
5
2024-05-07
patients admitted for an obstructive colon cancer
-
2024-513371-41-00
4
2024-04-25
Severe uveitis of Behçet’s disease
-
2023-504923-20-00
5
2024-04-04
Stage II, IIIA, IIIB (N2) Non-small Cell Lung Cancer
-
2023-508531-30-00
4
2024-03-25
grade 1 glioma/mixed glio-neuronal tumors or pleomorphic xanthoastrocy
-
2023-504863-17-00
5
2024-02-21
1. Lupus Erythematosus, Cutaneous, Subacute
2. Chronic Cutaneous Lupus
-
2023-504366-36-00
5
2024-02-17
de novo acute respiratory failure
-
2023-503865-48-00
4
2024-02-16
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
-
2023-505845-17-00
4
2024-02-08
Patients living with HIV-1 who are virologically controlled and carry